Resume

Sign in

Medical Clinical Research

Location:
Toronto, ON, Canada
Salary:
65.000-70.000
Posted:
April 14, 2020

Contact this candidate

Resume:

JAK OZSARFATI, MD, MSc

** ***** *******, *******, ******* M2N 5Y9

Tel. 647-***-****, E-mail: adcs4a@r.postjobfree.com,

https://ca.linkedin.com/in/jak-ozsarfati

EDUCATION

**** - **** ***, ********utical Science

Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON

Graduation Thesis “Pregnancy outcome after in-utero exposure to vitamin B2:

A cohort study”

1983 Graduation Thesis “Investigation of hypothalamic-pituitary-thyroid axis with

TRH test and growth hormone responses to TRH in children with short stature syndrome”

1979 – 1983 Specialty Training (Residency) in Paediatrics

Istanbul Medical Faculty, Istanbul Medical Faculty, Istanbul, Turkey

Received Certificate of Specialization in Paediatrics on October 20, 1983

1979 MD (Graduated as valedictorian)

Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey

1973 - 1979 Medical Education

Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey

TRAINING

2014 - 2016 Clinical Fellowship

Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children

University of Toronto, Toronto, ON.

June 2013 Low Level Laser Therapy (LLLT) Certification Training Program

Meditech International Inc., Etobicoke, Toronto, ON

CERTIFICATIONS

Canada

Clinical Research Associate Certificate - August 25, 2016

BioTalent Canada

Clinical Fellowship Certificate in Paediatric Clinical Pharmacology (Toxicology) – June 2016

University of Toronto, Department of Paediatrics

Low Intensity Laser Therapy Certification - June 2013

Meditech International Inc., Etobicoke, ON

Quality Assurance Manager Certificate - April 2013

BioTalent Canada

MCCEE (Medical Council of Canada Evaluating Examination Evaluation Examination) – Passed 2011

PROFILE

A foreign trained MD, paediatrician with many years of experience. Successfully passed the Medical Council of Canada Evaluating Examination (MCCEE) in 2011. Worked for 6 months as a Research Fellow in the Division of Clinical Pharmacology and Toxicology at The Hospital for Sick Children, Toronto, ON. Joined the same division as a Clinical Fellow and worked for 2 years until June 30, 2016. Completed his MSc in Pharmaceutical Science at Leslie Dan Faculty of Pharmacy, University of Toronto on December 2018. Currently working as a Clinical Research Associate in Meditech International Inc., Toronto.

ACADEMIC AND PROFESSIONAL INTERESTS

CLINICAL PHARMACOLOGY

Drug interactions

Pharmacogenomics, personalized medicine

Clinical trials - design and analysis

TOXICOLOGY

Reproductive toxicology

EMPLOYMENT HISTORY

May 2017-

Clinical Research Associate

Meditech International Inc., Etobicoke, Toronto, ON

Performs patient consultations and reviews patients’ medical reports and records and answers their questions.

Treats patients with LLLT (Low Level Laser Treatment) for various musculoskeletal and neurological diseases.

Treats patients with post concussion syndrome and other neurological disorders by using LLLT.

Counsels and educates patients regarding the use of LLLT at home.

Does literature search regarding LLLT use in different medical conditions.

Coordinates and conducts research projects.

Provides information to medical practitioners such as physiotherapists and chiropractors who are interested in this unique technology.

July 2014 - June 2016

Clinical Fellow, Division of Clinical Pharmacology &Toxicology

The Hospital for Sick Children, University of Toronto, Toronto, ON Canada

Responded to consultation requests from inpatient wards, Pediatric Intensive Care Unit (PICU) and Neonatal Intensive Care Unit (NICU) at The Hospital for Sick Children during on-calls. Examined patients for whom consultations were requested, prepared consultation reports and discussed with the multi-disciplinary team involved in the care of those patients.

Responded to Motherisk calls which consisted of requests for information from patients, doctors, nurses, pharmacists, social workers and other health care providers via telephone or fax. Motherisk is a specific reproductive toxicology program that focuses on the safety of medication use during pregnancy and breastfeeding.

Counselled patients in the Motherisk Clinic at The Hospital for Sick Children (under the supervision of Irena Nulman, MD, FRCPC and Shinya Ito, MD, FRCPC). The Motherisk Clinic is a special clinic where pregnant women or women who are planning pregnancy are referred regarding their medications for chronic and acute illnesses. These women are seen, counselled and followed in this clinic.

Examined and counselled patients referred to DART (Drug Allergy Reaction and Toxicology) Clinic at The Hospital for Sick Children (under the supervision of Shinya Ito, MD, FRCPC). The DART Clinic is a special clinic for patients who have had various kinds of toxic adverse drug reactions are seen and followed.

Examined and counselled patients referred to the Fetal Alcohol Spectrum Disorders (FASD) Clinic (under the supervision of Irena Nulman, MD, FRCPC). FASD Clinic is a special clinic for patients with suspected FASD are seen and followed.

Delivered many presentations in Fellow (Case Report), Breastfeeding and Motherisk Rounds.

Peer reviewed articles that were sent by scientific medical journals and discussed with the team.

Conducted research in the areas of Clinical Pharmacology and Reproductive Toxicology.

Delivered poster and oral presentations at international and local scientific conferences and meetings.

Involved in pediatric medical training of second year medical students in The Hospital for Sick Children.

January 2014 - June 2014

Research Fellow, Division of Clinical Pharmacology & Toxicology

The Hospital for Sick Children, University of Toronto, Toronto, ON

Coordinated and conducted studies in reproductive toxicology and clinical pharmacology.

Prepared all the required documents and study protocols and applied to REB (Research Ethic Board).

Coordinated all the communications between the study team and REB, and followed the approval of the study protocol.

Arranged and conducted specific training prior to the start of the study.

Screened for patients who fit the inclusion criteria, coordinated telephone calls, and arranged the recruitment process of patients according to study protocols.

Planned study logistics and monitored the timelines.

Interacted with study participants in a respectful and professional manner.

Interacted with Principal Investigator, Project Manager, and other study coordinators to ensure all aspects of protocols and study requirements were conducted as indicated in the protocol.

Managed and led the study team.

Maintained essential documents according to the regulatory agencies’ requirements.

Ensured quality control processes were followed.

Prepared Case Report Forms (CRF).

Monitored that all study-related activities are conducted according to protocol, SOPs (Standard Operating Procedures) and applicable regulations.

Prepared required amendments and submitted them to REB for any changes in the study that were not included in the protocol and following their approval.

Followed the study progress and updated the Project Manager regularly.

Had comprehensive knowledge of ICH-GCP.

Used conventional problem-solving techniques to identify the main problems of the study and determined the best course of action by discussing with the team members.

March 2013 - December 2013

Ryerson University, Toronto

Worked as a Research Fellow in the Data Science Laboratory Ryerson University, under the supervision of Professor Ayse Basar Bener, from the Mechanical and Industrial Engineering Department.

May 1987 - January 2012

American Hospital, Istanbul, Turkey

Worked as a paediatrician in the Neonatology Department and the Pediatric Outpatient Clinic.

Extensive experience in general paediatrics, perinatal care, breastfeeding, vaccinations and

infectious diseases.

May 1987 - January 2012

Private Medical Practice, Istanbul, Turkey

Extensive experience in general paediatrics, especially infections in infants and school children and immunization of children and well-baby care.

May 1985 - May 1987

Hakkari State Hospital, Hakkari, Turkey

Worked as a paediatrician in a public hospital in south-east Turkey, near the border with Iran and Iraq. During these two years served as the only paediatrician in this rural area with a regional population of 200,000.

Dec 1983 - April 1985

Infirmary of Turkish Military Academy

Worked as the only paediatrician in the Infirmary of Turkish Military Academy during mandatory military service.

PROFESSIONAL ACTIVITIES

POSTER PRESENTATIONS:

Poster presentation titled ‘Pregnancy Outcomes Following First Trimester Exposure to Topical Retinoids : A Systematic Review and Meta-analysis’ in Graduate Research Progress Symposium (GRIP) of The Graduate Department of Pharmaceutical Sciences at Leslie Dan Faculty of Pharmacy, Toronto, June 9, 2016.

Poster presentation titled “Pregnancy Outcome after In-Utero Exposure to Vitamin B 2: A Cohort Study Using Prospectively Collected Data from the Motherisk Program“ in Research Day, Department of Paediatrics, University of Toronto, May 18, 2016.

Poster presentation titled ‘Pregnancy Outcomes Following First Trimester Exposure to Topical Retinoids: A Systematic Review and Meta-analysis’ and ‘Severe Central Nervous System Depression in a Neonate Breastfed by a Mother Receiving Oxycodone. A case report and review’, Canadian Society of Pharmacology and Therapeutics 2015 Meeting, Toronto, June 8, 2015.

Poster presentation titled ‘Pregnancy Outcomes Following First Trimester Exposure to Topical Retinoids: A Systematic Review and Meta-analysis’, Sick Kids Research Institute Scientific Retreat Day, Toronto, June 5, 2015.

Poster presentation titled ‘Pregnancy Outcomes Following First Trimester Exposure to Topical Retinoids: A Systematic Review and Meta-analysis’ in Paediatric Research Day, Sick Kids, Toronto, May 28, 2015.

ORAL PRESENTATIONS - MEDICAL SCIENTIFIC MEETINGS:

Oral presentation titled ‘Severe Central Nervous System Depression in a Neonate Breastfed by a Mother Receiving Oxycodone. A case report and review’, Canadian Society of Pharmacology and Therapeutics 2015 Meeting, Toronto, June 10, 2015

NEWSPAPER ARTICLES:

“Skin problems in infants”. Sabah Newspaper, Istanbul, Turkey, April 3, 2009

“Throat and tonsil infections in childhood”. Haberturk Newspaper, Istanbul, Turkey,

December 28, 2009

AWARDS

1984 Dr.Cihat T. Gürson Foundation Award, Istanbul, Turkey

Received this award for thesis titled ‘Investigation of hypothalamic-pituitary-thyroid axis

with TRH test and growth hormone responses to TRH in children with short stature syndromes’

1977 Award - Association of Leprosy, Istanbul, Turkey

Wrote a paper titled “Leprosy in Modern Medicine”

1977 Award - Istanbul Medical Faculty, Istanbul, Turkey

Wrote a paper titled ‘Health problems in workers at the Kartal Cement Factory’

PROFESSIONAL MEMBERSHIPS

College of Physicians and Surgeons of Ontario

Turkish Pediatric Association

American Academy of Pediatrics

OBSERVERSHIPS

Sep 2013 - Dec 2013

Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, Toronto, ON

Worked with Dr. Gideon Koren

April 2012 - June 2012

Division of Pediatric Rheumatology, The Hospital for Sick Children, Toronto, ON

Worked with Dr. Ronald Laxer

JOURNAL ARTICLES

1. Koren G, Carnevale A, Ling J, Ozsarfati J, Kapur B, Bagli D. Fetal exposure to polybrominated diphenyl ethers and the risk of hypospadias: focus on the congeners involved. J Pediatr Urol. 2019 Jun 4. pii: S1477-5131(19)30143-3.

2. Poon S, Koren G, Carnevale A, Aleksa K, Ling J, Ozsarfati J, Kapur BM, Bagli D. Association of in utero exposure to polybrominated diphenyl ethers with the risk of hypospadias. JAMA Pediatr. 2018 Sep 1;172(9):851-856

3.Kaplan YC, Ozsarfati J, Nickel C, Koren G. Reproductive outcomes following hydroxychloroquine use for autoimmune diseases: a systematic review and meta-analysis. Br J Clin Pharmacol. 2016 May; 81(5):835-48.

4.Kaplan YC, Ozsarfati J, Etwel F, Nickel C, Nulman I, Koren G. Pregnancy Outcomes Following First Trimester Exposure to Topical Retinoids: A Systematic Review and Meta-analysis. Br J Dermatol. 2015 Nov; 173(5):1132-41.

5. Ozsarfati J, Koren G. Medications used in the treatment of disruptive behavior in children with FASD-a guide. J Popul Ther Clin Pharmacol. 2015; 22(1):e59-67. Epub 2015 Feb 12

6.Neyzi O, Çelenk A, Ozsarfati J, Sait (Bundak) R, Yenerer N,Saka N. The correlation between birth weight and mother’s body size. XXIth Turkish Pediatric Congress. Pediatric Neurology. 1983; p.493-496

7. Günöz H, Ozsarfati J, Neyzi O. DeSanctis-Cacchione Syndrome. Turk J Pediatr 1982; 24(3):193-7

8. Gedikoğlu G, Sıdal M, Can G, Abban Z, Neyzi O, Günöz H, Ozsarfati J. Leukemia and diabetes insipidus. XIXth Turkish Pediatric Congress, July 2-5, 1980, Istanbul, Book of Congress, p.173

9. Gedikoğlu G, Sıdal M, Ozsarfati J, Koç L. Deux cas de glycogenose type IV. Resumes de la XVIII semain L’Union Medicale Balcanique, 1982, Sofia, Vol II p. 36

THESES

MSc Thesis-January 2019

Pregnancy outcome after in-utero exposure to vitamin B2: A cohort study.

Graduation Thesis in Paediatrics-October 1983

Investigation of hypothalamic-pituitary-thyroid axis with TRH test and growth hormone responses to TRH in children with short stature syndrome



Contact this candidate